Trials / Recruiting
RecruitingNCT07085299
Gut Microbiota and Prognostic Outcomes in Intracranial Arterial Stenosis Patients(GROW-ICAS)
Correlation Study Between Gut Microbiota and Prognosis in Patients With Intracranial Arterial Stenosis(GROW-ICAS)
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 500 (estimated)
- Sponsor
- Nanjing First Hospital, Nanjing Medical University · Academic / Other
- Sex
- All
- Age
- 30 Years – 80 Years
- Healthy volunteers
- —
Summary
GROW-ICAS (Gut microBiota and prOgnostic Outcomes in IntraCranial Arterial Stenosis) is a prospective observational cohort study that enrolls patients with intracranial arterial stenosis to investigate the correlations between their gut microbiota, metabolomic, and transcriptomic profiles and three key clinical domains: functional outcomes, vascular plaque imaging characteristics, and post-stroke non-motor dysfunctions (including cognitive impairment, depression, anxiety, and fatigue).
Conditions
Timeline
- Start date
- 2025-06-01
- Primary completion
- 2028-12-31
- Completion
- 2028-12-31
- First posted
- 2025-07-25
- Last updated
- 2025-07-25
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT07085299. Inclusion in this directory is not an endorsement.